Phoenix Data Systems

News & Events

Phoenix Data Systems CEO Named to the 2006 PharmaVOICE 100

King of Prussia, Pa., August 14, 2006 – Phoenix Data Systems (PDS), a leading provider of full service electronic data capture (EDC), announces that Dr. William Claypool, M.D., CEO of PDS, has been named to the PharmaVOICE 100 by PharmaVOICE magazine. The annual list highlights industry thought leaders who most influence corporate strategy, business development, research and development, marketing and creativity, technology, leadership and innovation in the field.

"Through their actions and passion for the industry, the PharmaVOICE 100 serve as inspiring examples of how one person can make a difference to many," said Taren Grom, editor of PharmaVOICE. "We are honored to pay tribute to these unique individuals, who have been recognized by the readers of the publication for their positive contributions to the industry. We are pleased to showcase these individuals who are making a difference in our second annual PharmaVOICE 100 issue.”

As CEO of PDS and Chairman of its Board of Directors, Dr. Claypool has molded an organization focused on delivering innovation through technology-driven services to the biopharmaceutical industry. As a result, PDS has experienced outstanding growth over the last five years, emerging as a leader in the EDC marketplace.

As VP for Worldwide Clinical Development and Medical Affairs at SmithKline Beecham Pharmaceuticals in the 1990s, Dr. Claypool oversaw all clinical research programs for SmithKline Beecham (Phases I - IV). He established EDC (then called RDE) as the preferred data entry platform in R&D before the merger with Glaxo. Dr. Claypool joined PDS in 2001 and implemented a unique system and business model that has helped sponsors improve patient safety and monitoring, weed-out unproductive trials and take maximum advantage of opportunities to modify and improve their clinical studies.

“It’s a great honor to be recognized by PharmaVOICE amongst such prestigious company,” said Dr. Claypool. “Pharmaceutical research is one of the most advanced and complex areas of scientific research and we are proud to be pioneers in supporting this work. I’m grateful for the support from our clients and the teamwork and dedication of all of our marvelous people. It all comes down to our basic philosophy of treating clients the way we would want to be treated.”